KEROS THERAPEUTICS INC

Ticker: KROS CUSIP: 492327101 Class: Common Stock

Candriam S.C.A.'s Holding History (CIK: 0001537014)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 345,384 Value ($000) $20,056 Avg Close $49.39 Range $40.93 - $59.06
Q2 2024
Shares 441,855 Value ($000) $20,192 Avg Close $53.73 Range $43.30 - $67.30
Q1 2024
Shares 651,999 Value ($000) $43,162 Avg Close $59.30 Range $39.00 - $73.00
Q4 2023
Shares 819,062 Value ($000) $32,567 Avg Close $31.36 Range $27.02 - $41.92
Q3 2023
Shares 741,061 Value ($000) $23,625 Avg Close $37.33 Range $31.17 - $44.95
Q2 2023
Shares 721,061 Value ($000) $28,972 Avg Close $43.84 Range $37.03 - $51.16
Q1 2023
Shares 745,057 Value ($000) $29,283 Avg Close $50.51 Range $39.98 - $59.96
Q4 2022
Shares 625,914 Value ($000) $30,055 Avg Close $46.71 Range $37.40 - $52.78
Q3 2022
Shares 361,789 Value ($000) $13,611 Avg Close $34.66 Range $26.34 - $42.15
Q2 2022
Shares 361,789 Value ($000) $9,995 Avg Close $43.88 Range $24.38 - $68.29
Q1 2022
Shares 420,670 Value ($000) $22,875 Avg Close $51.33 Range $39.75 - $60.42
Q4 2021
Shares 240,946 Value ($000) $14,098 Avg Close $49.87 Range $36.13 - $63.47
Q3 2021
Shares 240,946 Value ($000) $9,531 Avg Close $35.59 Range $28.50 - $44.87
Q2 2021
Shares 101,409 Value ($000) $4,307 Avg Close $54.17 Range $41.88 - $71.74